McAb共激活;肝癌细胞;膜分子;TCRVβ基因

CD28/CD80和CD2/CD58活化PBLs作用肝癌细胞的表型分析与TCR Vβ基因亚家族的优势取用

http://www.100md.com 1999年12月15日《世界华人消化杂志》 1999年第12期

McAb共激活;肝癌细胞;膜分子;TCRVβ基因,CD28,CD80和CD2,CD58活化PBLs作用肝癌细胞的表型分析与TCRVβ基因亚家族的优势取用,国家自然科学基金,39770698和广东省自然科学基金980838资助.,项目负责人,SupportedbyNationalNaturalScienceFoundation39770698andNaturalScience,Fou

     广东省药学院分子生物学研究室广东省广州市 510224

    肖兰凤，副教授，1978年毕业于湖北医科大学，现于广东药学院从事肿瘤生物治疗的研究.

    国家自然科学基金39770698和广东省自然科学基金980838资助.

    项目负责人黄树林，510224，广东省药学院分子生物学研究室.

    Supported by National Natural Science Foundation 39770698 and Natural Science

    Foundation of Guangdong Province 980838.

    Correspondence to Shu-Lin Huang, Research Center of Molecular Biology, Guangdong Pharmaceutical College, Guangzhou 510224, Guangdong Province, China

    收稿日期 1999-11-04

    Study of the phenotype of PBLs activated by CD28/CD80 and CD2/CD58 and acting with hepatoma cells and the restricted usage of TCR Vβ gene subfamily

    Lan-Feng Xiao, Li-Qiong Luo, Yi Zou and Shu-Lin Huang

    The Research Center of Molecular Biology, Guangdong Pharmaceutical College, Guangzhou 510224, Guangdong Province, China

    Abstract

    AIM To study the difference of the phenotype of PBLs and the expression of TCR Vβ subfamily in liver before and after stimulation by anti-CD28, anti-CD80, anti-CD2 and anti-CD58 and then acting with hepatoma cell. ......

    百拇医药网 http://www.100md.com/html/DirDu/1999/12/15/69/55/70.htm

您现在查看是摘要页，全文长 11368 字符。